ZA966027B - The use of sertraline to treat post myocardial infarction patients. - Google Patents
The use of sertraline to treat post myocardial infarction patients.Info
- Publication number
- ZA966027B ZA966027B ZA9606027A ZA966027A ZA966027B ZA 966027 B ZA966027 B ZA 966027B ZA 9606027 A ZA9606027 A ZA 9606027A ZA 966027 A ZA966027 A ZA 966027A ZA 966027 B ZA966027 B ZA 966027B
- Authority
- ZA
- South Africa
- Prior art keywords
- sertraline
- myocardial infarction
- post myocardial
- infarction patients
- treat post
- Prior art date
Links
- 208000010125 myocardial infarction Diseases 0.000 title abstract 2
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2
- 229960002073 sertraline Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US143795P | 1995-07-17 | 1995-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA966027B true ZA966027B (en) | 1998-01-16 |
Family
ID=21696010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9606027A ZA966027B (en) | 1995-07-17 | 1996-07-16 | The use of sertraline to treat post myocardial infarction patients. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0768083B1 (fr) |
| JP (1) | JPH0930959A (fr) |
| KR (1) | KR970005283A (fr) |
| CN (1) | CN1147937A (fr) |
| AT (1) | ATE235237T1 (fr) |
| AU (1) | AU721967B2 (fr) |
| CA (1) | CA2181225C (fr) |
| DE (1) | DE69626916T2 (fr) |
| DK (1) | DK0768083T3 (fr) |
| ES (1) | ES2192217T3 (fr) |
| IL (1) | IL118833A (fr) |
| MY (1) | MY117638A (fr) |
| NZ (1) | NZ299006A (fr) |
| PT (1) | PT768083E (fr) |
| ZA (1) | ZA966027B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0980241B1 (fr) * | 1997-07-01 | 2003-12-17 | Pfizer Products Inc. | Formes posologiques de sertraline, en solution et encapsulees dans de la gelatine |
| CA2290966C (fr) | 1997-07-01 | 2005-12-20 | Pfizer Inc. | Sels de sertraline et formes posologiques de sertraline, a liberation prolongee |
| GB9714841D0 (en) * | 1997-07-14 | 1997-09-17 | Smithkline Beecham Plc | Treatment method |
| ES2209490T3 (es) * | 1998-10-13 | 2004-06-16 | Pfizer Products Inc. | Concentrado oral de sertralina. |
| US6727283B2 (en) * | 1998-10-13 | 2004-04-27 | Pfizer Inc. | Sertraline oral concentrate |
| US6245782B1 (en) | 1999-05-17 | 2001-06-12 | Heartdrug Research L.L.C. | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors |
| GB0814466D0 (en) * | 2008-08-07 | 2008-09-10 | Rosemont Pharmaceuticals Ltd | Sertraline composition |
| JP2022532637A (ja) * | 2019-05-15 | 2022-07-15 | バステラ カンパニー リミテッド | オートファジー活性化剤を有効成分として含む心脳血管疾患の予防または治療用組成物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
-
1996
- 1996-07-03 AT AT96304906T patent/ATE235237T1/de not_active IP Right Cessation
- 1996-07-03 DK DK96304906T patent/DK0768083T3/da active
- 1996-07-03 ES ES96304906T patent/ES2192217T3/es not_active Expired - Lifetime
- 1996-07-03 PT PT96304906T patent/PT768083E/pt unknown
- 1996-07-03 EP EP96304906A patent/EP0768083B1/fr not_active Expired - Lifetime
- 1996-07-03 DE DE69626916T patent/DE69626916T2/de not_active Expired - Fee Related
- 1996-07-11 IL IL11883396A patent/IL118833A/xx not_active IP Right Cessation
- 1996-07-12 JP JP8200995A patent/JPH0930959A/ja active Pending
- 1996-07-15 CN CN96110584A patent/CN1147937A/zh active Pending
- 1996-07-15 CA CA002181225A patent/CA2181225C/fr not_active Expired - Fee Related
- 1996-07-16 NZ NZ299006A patent/NZ299006A/xx unknown
- 1996-07-16 AU AU60534/96A patent/AU721967B2/en not_active Ceased
- 1996-07-16 KR KR1019960028767A patent/KR970005283A/ko not_active Ceased
- 1996-07-16 MY MYPI96002925A patent/MY117638A/en unknown
- 1996-07-16 ZA ZA9606027A patent/ZA966027B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6053496A (en) | 1997-01-23 |
| PT768083E (pt) | 2003-08-29 |
| DE69626916D1 (de) | 2003-04-30 |
| DE69626916T2 (de) | 2003-10-09 |
| MY117638A (en) | 2004-07-31 |
| DK0768083T3 (da) | 2003-06-23 |
| CA2181225C (fr) | 1999-03-23 |
| EP0768083A2 (fr) | 1997-04-16 |
| JPH0930959A (ja) | 1997-02-04 |
| EP0768083A3 (fr) | 1999-12-01 |
| EP0768083B1 (fr) | 2003-03-26 |
| ES2192217T3 (es) | 2003-10-01 |
| AU721967B2 (en) | 2000-07-20 |
| IL118833A0 (en) | 1996-10-31 |
| NZ299006A (en) | 2000-08-25 |
| CN1147937A (zh) | 1997-04-23 |
| IL118833A (en) | 2000-07-26 |
| CA2181225A1 (fr) | 1997-01-18 |
| KR970005283A (ko) | 1997-02-19 |
| ATE235237T1 (de) | 2003-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU609664B1 (en) | A method of treating premature ejaculation using sertraline | |
| EP0703785A4 (fr) | Procedes de traitement de maladies et de troubles musculaires | |
| MY106075A (en) | A method of treating anxiety-related disorders using sertraline. | |
| IL118833A0 (en) | The use of sertraline to treat post myocardial infarction patients | |
| CA2167257A1 (fr) | Utilisation de sertraline pour traiter les malades atteints de cancer | |
| NZ268110A (en) | Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage | |
| HU905683D0 (en) | The treatment of drug dependence by using sertraline | |
| NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
| UA29461C2 (uk) | Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу | |
| MX9602793A (es) | Uso de sertralina para tratar pacientes despues de un infarto de miocardio. | |
| NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease | |
| MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. |